15h
FDA Clears OsteoProbe® (K250216): First-Ever Device Indication for Measuring Bone Material Strength
Current diagnostic tools, like dual-energy X-ray absorptiometry (DXA), primarily measure bone mineral density (BMD), which explains only about 70% of bone strength variability. OsteoProbe® addresses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback